We here for the first time studied the role of PAR-1 in respiratory tract infection, using our well-established clinically relevant model of pneumococcal pneumonia, comparing survival, antibacterial defense and inflammatory responses in PAR-1 knockout (KO) and normal wild-type (WT) mice. This evidence concerns the gene F2R and pneumococcal pneumonia.